335 reports of this reaction
3.5% of all ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE reports
#2 most reported adverse reaction
NAUSEA is the #2 most commonly reported adverse reaction for ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE, manufactured by Kenvue Brands LLC. There are 335 FDA adverse event reports linking ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE to NAUSEA. This represents approximately 3.5% of all 9,511 adverse event reports for this drug.
Patients taking ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NAUSEA is moderately reported among ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE users, representing a notable but not dominant share of adverse events.
In addition to nausea, the following adverse reactions have been reported for ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE:
The following drugs have also been linked to nausea in FDA adverse event reports:
NAUSEA has been reported as an adverse event in 335 FDA reports for ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
NAUSEA accounts for approximately 3.5% of all adverse event reports for ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE, making it one of the most commonly reported side effect.
If you experience nausea while taking ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.